In this study, we demonstrated that transplantation of Smad3-deficient islets produced a better therapeutic effect on diabetes and diabetic kidney injury in STZ-induced diabetic mice and in db/db mice. The gene discussed is SMAD3; the disease is diabetes mellitus.